发明名称 STAT3 INHIBITORS FOR THE TREATMENT OF FIBROSIS
摘要 <p>A method of medical treatment or prevention of an interstitial lung disease (ILD) in a subject in need thereof, the method including administering a therapeutically effective amount of a signal transducer and activator of transcription 3 (STAT3) inhibitor to the subject is provided. In other aspects uses of STAT3 inhibitors for treatment and/or prevention of an ILD, or for preparation of medicaments for treatment or prevention of an ILD are provided. The method or use may further include coupling the STAT3 inhibitor to a targeting moiety.</p>
申请公布号 WO2009059425(A1) 申请公布日期 2009.05.14
申请号 WO2008CA01971 申请日期 2008.11.07
申请人 THE UNIVERSITY OF BRITISH COLUMBIA;UNIVERSITY OF WESTERN AUSTRALIA;LUDWIG INSTITUTE FOR CANCER RESEARCH LTD;KNIGHT, DARRYL ANDREW;MUTSAERS, STEVEN EUGENE;O'DONOGHUE, ROBERT JOSEPH JAMES;ERNST, MATTHIAS ROBER WALTER 发明人 KNIGHT, DARRYL ANDREW;MUTSAERS, STEVEN EUGENE;O'DONOGHUE, ROBERT JOSEPH JAMES;ERNST, MATTHIAS ROBER WALTER
分类号 A61K31/575;A61K9/00;A61K9/72;A61K31/122;A61K31/202;A61K31/381;A61K31/42;A61K31/7105;A61K38/17;A61K45/00;A61K47/48;A61K48/00;A61P11/00;C12Q1/02 主分类号 A61K31/575
代理机构 代理人
主权项
地址